Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How much is mebendazole?Generic brand for latisse?When is the expected fda decision date for apotex's ruxolitinib resubmission?Bivalirudin manufacturer?Guselkumab loss of exclusitivy?
See the DrugPatentWatch profile for Hysingla
Hysingla ER is the brand name for an extended-release opioid formulation of hydrocodone (generic name: hydrocodone bitartrate, used for the ER product) [1].
The “ER” stands for extended-release, meaning the medication is designed to release hydrocodone slowly over time rather than all at once [1].
Because Hysingla is specifically formulated as hydrocodone ER, generic labeling often appears as hydrocodone bitartrate extended-release tablets/capsules, reflecting both the drug and the extended-release form [1].
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200347
Other Questions About Hysingla :